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CC10 clones. The HUWE1 gRNA-3840 plasmid was transfected into A549 cells and single-cell culture was established using the limiting dilution method. Sanger sequencing was performed to detect HUWE1 mutations in A549 AA1 , A549 CF5 , A549 AD11 , and A549 CC10 clones. The PAM sequence was marked in red.
Supplementary Fig. 3 Supplementary Fig. 3 Flow cytometry analysis for the cell cycle of the indicated cells. The cells were collected when they were in a confluency between 50-60%, and cell cycle analysis was performed as described in materials and methods. Supplementary Fig. 4 Supplementary Fig. 4 Deletion of HUWE1 didn't induce apoptosis in A549 cell. presented as the mean ± SD (***, P < 0.001, unpaired t-test).
(B) Growth curves for A549/teton-shHUWE1 cells with or without DOX. A549/tetonshHUWE1 cells were treated with Dox for 2 days, then planted in 12-well plates. The number of cells was counted every 12 hours. The data were presented as the means ± SD (**, P < 0.01, unpaired t-test).
(C) BrdU incorporation assay was used to evaluate the DNA synthesis and proliferation rates of A549/teton-shHUWE1 cells with or without DOX. The data are presented as the means ± SD (***, P < 0.01, unpaired t-test).
(D) Soft agar colony formation assays for A549/teton-shHUWE1 cells with or without DOX.
(E) A549/teton-shHUWE1 cells were treated with Dox for 5 days, then cleaved-caspase 3 antibody was used to detect cell apoptosis. Thapsigargin was used as the positive control to induce A549 cells apoptosis.
Supplementary Fig. 7 Supplementary Fig. 7 HUWE1 knockdown impaired the tumorigenicity of lung cancer cells. HUWE1, Ki67, and cleaved (Cl)-caspase 3 staining in cancer tissues described in Fig.3E at day 7 and day 32 after doxycycline (DOX) treatment.
Supplementary Fig. 8 Supplementary 
